Patients with presumed germline retinoblastoma due to RB1 mutation for Retinoblastoma
Recruiting1 award2 criteria
Seattle, Washington
The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin for valuable insight into the genotype-phenotype relationship of this cancer syndrome.
Device
Intensive CPAP Support for Stroke Patients with Sleep Apnea
Recruiting1 award2 criteria
Seattle, Washington
This trial is testing if a program that provides intensive support for using a CPAP machine is more effective than the standard care for stroke patients with sleep apnea during rehabilitation. They will have 250 participants
Behavioural Intervention
Medical Note Access for Hospitalized Children
Recruiting1 award1 criteria
Seattle, Washington
This trial will test if giving parents access to their child's medical notes on a tablet by their bedside helps them get more involved in their care and identify safety concerns. Parents of hospitalized children will be randomly
Popular Filters
Phase 3 Trials
Aviptidil + SOC for Coronavirus
Recruiting1 awardPhase 3
Seattle, Washington
This study looks at the safety and effectiveness of Aviptidil in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Aviptidil plus current standard of care (SOC), or with placebo plus current SOC.
Remdesivir + SOC for Coronavirus
Recruiting1 awardPhase 3
Seattle, Washington
This study looks at the safety and effectiveness of Remdesivir in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Remdesivir plus current standard of care (SOC), or with placebo plus current SOC.
Behavioural Intervention
Lumateperone for Autism
Recruiting1 awardPhase 3
Everett, Washington
This trial is testing a new medication for irritability in children with Autism Spectrum Disorder. It will involve multiple medical centers and the participants will be randomly assigned to receive either the new medication or a placebo.
Trials With No Placebo
Anti-tumor antibiotic
Personalized Chemotherapy for Hodgkin's Lymphoma
Recruiting1 awardPhase 2
Seattle, Washington
This trial is testing whether adjusting chemotherapy based on levels of circulating tumor DNA (ctDNA) can effectively treat patients with advanced Hodgkin lymphoma. By measuring ctDNA levels in the blood, doctors can
Behavioral Intervention
PREVENT Intervention for Increasing HPV Vaccination
Recruiting1 award
Seattle, Washington
This trial aims to develop and test strategies to increase HPV vaccination rates among rural parents and caregivers of children aged 9-17 in the Mountain West. The goal is to reduce HPV-related cancer disparities in
Participants With Signs and Symptoms of Acute Coronary Syndromes for Heart Attack
Recruiting1 award10 criteria
Redmond, Washington
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Behavioral Intervention
Care Navigation for Addiction
Recruiting1 award1 criteria
Seattle, Washington
This trial aims to improve access to treatment for substance use disorder. It will involve care coordinators at a mental health access center in Washington. Patients seeking help for substance use disorder will either receive standard care
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.